ロード中...
It’s time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancer
The peritoneal spread of ovarian cancer makes it a potential target for hyperthermic intraperitoneal chemotherapy (HIPEC). Intraperitoneal delivery exposes the tumor to concentrations of cytotoxic drugs much greater than with intravenous delivery, and in vitro studies have also shown that combining...
保存先:
| 出版年: | Gynecol Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6684262/ https://ncbi.nlm.nih.gov/pubmed/30249527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2018.09.007 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|